College of Pharmacy is part of the University of Arizona, a public university in Tucson, Arizona, United States. It is the only pharmacy school at a public Arizona university and one of four health professions colleges at the Arizona Health Sciences Center campus. The college is accredited by the Accreditation Council for Pharmacy Education.
History
In September 1947, the School of Pharmacy opened as part of the University of Arizona Liberal Arts College. Eighty-three students were enrolled. It became a full-fledged college in 1949, with 206 students and seven faculty members. Faculty and staff moved into new pharmacy building on the Arizona Health Sciences Center part of the campus in 1982. Faculty and students also have offices and classrooms in Roy P. Drachman Hall, next to the Pharmacy building. In 2007, the College of Pharmacy opened an office on the Phoenix Biomedical Campus.
Deans
Rufus Lyman, MD, 1947–1950
Haakon Bang, PhD, 1950–1952
Willis R. Brewer, PhD, 1952–1975
Albert L. Picchioni, PhD, 1975–1977
Jack R. Cole, PhD, 1977–1989
J. Lyle Bootman, PhD, ScD, 1987–2015
Rick G. Schnellmann, PhD, 2016–present
Academic departments
Pharmacy Practice and Science
The Department of Pharmacy Practice and Science is responsible for providing instruction in how to be a pharmacist and teaches courses such as pharmacokinetics, patient assessment and quality improvement and medication error reduction. The Department of Pharmacy Practice and Science faculty oversee includes clinical studies and case overviews and experiential learning.
Pharmacology and Toxicology
The Department of Pharmacology and Toxicology is responsible for providing instruction in pharmacology, toxicology and medicinal chemistry to PharmD students and for providing graduate education to students in a variety of research tracks.
Admissions
PharmD
The PharmD degree program is for students wishing to become pharmacists. The College of Pharmacy at the University of Arizona currently admits classes of 100 student pharmacists each fall semester. To qualify for admission to the PharmD program at the University of Arizona College of Pharmacy, an applicant for Fall admissions must complete 71 units/credits of specific pre-pharmacy courses. The Admissions Committee invites candidates to interview for admission to the college based upon the following criteria: a competitive science GPA PCAT score at least 50 hours of work or volunteer experience in a pharmacy setting three strong letters of recommendation community involvement
Graduate
Graduate degree programs (MS and PhD) are offered in pharmaceutical sciences and in pharmacology and toxicology. The specific tracks within the UA College of Pharmacy Graduate Studies Program do not accept applications for the spring semester admission. Applications are only accepted for fall semester admission. Applicants must meet the University of Arizona’s graduate admissions criteria.
Class statistics
According to the Fall of 2016 data, the number of students in the PharmD program is 432 and there are 50 postgraduate students.
The majority of PharmD students come from Arizona (90% of the graduating Class of 2017). Enrollment is about 62% female and the average age is about 23 years old. The average science GPA for the Class of 2017 is 3.53 and average cumulative GPA is 3.59.
Centers
Center for Toxicology
The center is the home for UA research and training toxicology programs at the university.
Southwest Environmental Health Sciences Center
The Southwest Environmental Health Sciences Center investigates mechanisms by which exposures to environmental agents (and other stresses) contribute to human disease.
Superfund Research Program
The UA Superfund Research Program is a collaborative research program among toxicologists, environmental scientists and environmental engineers from many University of Arizona colleges who address hazardous waste problems of the Southwest.
Center for Health Outcomes and PharmacoEconomic Research
The Center for Health Outcomes and PharmacoEconomic Research (HOPE) focuses on cost-effectiveness analysis of drug therapies, quality-of-life assessment, pharmaceutical policy analysis and drug-use evaluation